Haleos Labs Ltd (HALEOSLABS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 540679 | NSE: HALEOSLABS | Pharmaceuticals & Drugs | Small Cap

Haleos Labs Share Price

1,374.90 0.00 0.00%
as on 04-Dec'25 16:59

Haleos Labs Ltd (HALEOSLABS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 540679 | NSE: HALEOSLABS | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Haleos Labs

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Haleos Labs stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
21.83
Market Cap:
415.7 Cr.
52-wk low:
956.1
52-wk high:
1,680

Is Haleos Labs Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Haleos Labs: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Haleos Labs Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%45.7%9.5%21.8%11.7%14.4%19.7%10.2%10.9%14%-
Value Creation
Index
NA2.3-0.30.6-0.20.00.4-0.3-0.20-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0216213344257260346315300333325
Sales YoY Gr.-NA-1.3%61.6%-25.4%1.3%32.8%-8.8%-4.8%11.1%-
Adj EPS -1.912,173.416.450.727.141.45237.538.86763
YoY Gr.-NA-99.9%209.7%-46.5%52.6%25.7%-27.8%3.5%72.7%-
BVPS (₹) -8.281,838.7292.4347.2374.6417.9500.2542.6582.9652.2684.3
Adj Net
Profit
-012.2515.38.212.515.711.411.720.319
Cash Flow from Ops. 019.7827.31421.6-14.74.614.828-
Debt/CF from Ops. 01.33.41.73.52.1-4.118.662.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA5.4%-1.2%11.1%
Adj EPS NA19.8%8.8%72.7%
BVPSNA11.7%9.3%11.9%
Share Price - 15.9% 29.3% 19.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-67.529.85.815.87.510.511.37.26.910.99.4
Op. Profit
Mgn %
013.26.29.59.311.59.18.411.513.312.4
Net Profit
Mgn %
05.62.34.53.24.84.63.63.96.15.9
Debt to
Equity
-0.40.30.30.50.40.40.40.50.50.40.1
Working Cap
Days
08515811415915515018219918694
Cash Conv.
Cycle
013371923282446686329

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Haleos Labs Ltd.

Standalone Consolidated
TTM EPS (₹) 63 61.9
TTM Sales (₹ Cr.) 325 338
BVPS (₹.) 684.3 682.8
Reserves (₹ Cr.) 204 203
P/BV 2.01 2.01
PE 21.83 22.23
From the Market
52 Week Low / High (₹) 956.05 / 1680.00
All Time Low / High (₹) 134.85 / 1747.85
Market Cap (₹ Cr.) 416
Equity (₹ Cr.) 3
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Haleos Labs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *3.413.410.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Haleos Labs - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Haleos Labs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0216213344257260346315300333
Operating Expenses 0187200312233230314289265289
Manufacturing Costs0424048384759505157
Material Costs0120133230162140208190162169
Employee Cost 0171821232733354146
Other Costs 08913101714131118
Operating Profit -0281332243031263544
Operating Profit Margin (%) -13.2%6.2%9.4%9.3%11.5%9.1%8.4%11.5%13.3%
Other Income 0233212344
Interest 0645555598
Depreciation 066677881010
Exceptional Items 00000013200
Profit Before Tax -018624131933181930
Tax 06-07468569
Profit After Tax -01371791325131321
PAT Margin (%) -6.0%3.1%4.8%3.6%5.1%7.3%4.2%4.4%6.4%
Adjusted EPS (₹)-1.912,943.221.555.030.343.684.043.743.270.7
Dividend Payout Ratio (%)0%0%0%3%0%3%2%3%3%2%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 08288105113126151164176197
Share Capital 0033333333
Reserves -08285102110123148161173194
Minority Interest0000000000
Debt0202140454254767568
Long Term Debt0161527242227462817
Short Term Debt04613212027304750
Trade Payables0554484456271555046
Others Liabilities 0242428294643465156
Total Liabilities 0181178257232276319341352367

Fixed Assets

Gross Block07880104118131128183191213
Accumulated Depreciation061117243029435362
Net Fixed Assets 07368879410199140138150
CWIP 00712321160
Investments 00526262623232323
Inventories0444974615981807561
Trade Receivables0392737223034464965
Cash Equivalents 0012292111
Others Assets 0252030244959505967
Total Assets 0181178257232276319341352367

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0208271422-1551528
PBT 018624131920161930
Adjustment 0989111011121519
Changes in Working Capital 0-2-61-7-3-38-19-17-12
Tax Paid 0-5-1-6-3-5-8-4-3-9
Cash Flow From Investing Activity 0-8-7-43-13-6-7-28-14-14
Capex 0-8-3-22-13-7-15-28-14-14
Net Investments 0-1-3-21-0180-0-0
Others 0100000000
Cash Flow From Financing Activity 0-12-118-2-81523-1-14
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0-8-113-6-4824-9-13
Interest Paid 0-3-2-2-3-3-2-2-5-4
Dividend Paid 0000-10-0-0-0-0
Others 0-1278-191143
Net Cash Flow 0-002-18-8-100

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/A31.637.6417.28.3810.9918.298.397.6811.45
ROCE (%)N/A45.729.4821.8211.7314.3619.7310.2310.9414.03
Asset Turnover Ratio02.531.311.731.161.131.271.070.951.02
PAT to CFO Conversion(x)N/A1.541.141.591.561.69-0.60.381.151.33
Working Capital Days
Receivable Days0625131383331415356
Inventory Days0707260877667848667
Payable Days084137102145140116120117103

Haleos Labs Ltd Stock News

Haleos Labs Ltd FAQs

The current trading price of Haleos Labs on 04-Dec-2025 16:59 is ₹1,374.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Dec-2025 the market cap of Haleos Labs stood at ₹415.7.
The latest P/E ratio of Haleos Labs as of 03-Dec-2025 is 21.83.
The latest P/B ratio of Haleos Labs as of 03-Dec-2025 is 2.01.
The 52-week high of Haleos Labs is ₹1,680 and the 52-week low is ₹956.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Haleos Labs is ₹325.2 ( Cr.) .

About Haleos Labs Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×